Eris Lifesciences (NSE:ERIS) Short Interest


NSE:ERIS Eris Lifesciences Ltd NSE:ERIS
91 GF Score
Price ₹1,459.00
GF Value ₹1,642.12
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Eris Lifesciences Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:ERIS vs ZTS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eris Lifesciences Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's Short Interest distribution charts can be found below:

* The bar in red indicates where Eris Lifesciences's Short Interest falls into.


NSE:ERIS
91GF Score
Eris Lifesciences Ltd NSE:ERIS
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Eris Lifesciences (NSE:ERIS) Overvalued in 2026?

Based on GuruFocus' analysis, Eris Lifesciences stock appears to be undervalued. The current stock price of ₹1,459.00 is trading 11.2% below its estimated GF Value™ of ₹1,642.12. GuruFocus considers Eris Lifesciences to be Modestly Undervalued.

Key valuation signals for NSE:ERIS:

  • Short Interest:
  • GF Value™: ₹1,642.12 vs. price of ₹1,459.00 (11.2% below fair value)
  • GF Score™: 91/100 with 6 warning signs

No single metric tells the full story. See the NSE:ERIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eris Lifesciences Business Description

Other Exchanges 540596:India
Address Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054
Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast. The company works basically within India and International with the majority of revenue from India.
91GF Score

Get the complete analysis for NSE:ERIS

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,459.00
Price
₹1,642.12
GF Value